IPBS teams receive six grants from the French National Research Agency
Towards novel anti-TB drugs With 1.4 million deaths and 10 million new cases each year,[…]
A new ‘cell saboteur’ against SARS-CoV-2
The inflammation observed in patients infected with SARS-CoV-2, the virus responsible for COVID-19, suggests that[…]
Horizon Europe: IPBS is involved in the projects GOLIAT and ETAIN
GOLIAT and ETAIN are two of the 15 projects (selected from 83 proposals) funded by[…]
Pierre Dupuy is awarded a Marie Skłodowska-Curie postdoctoral fellowship
Pierre Dupuy is awarded a Marie Skłodowska-Curie Actions (MSCA) Postdoctoral individual scholarship to study the[…]
Julien Marcoux is awarded a grant from the France-Arizona Institute for Global Grand Challenges
The France-Arizona Institute for Global Grand Challenges facilitates best-in-class international research, focusing on the grandest[…]
Cancer Treatment: Identification of the blood vessels that allow killer lymphocytes to access and destroy tumors
Immunotherapy, a therapeutic strategy aimed at increasing the activity of the immune system in order[…]
Rémi Mascarau is awarded the Young Researcher prize from the Fondation des Treilles
© F. Viala, IPBS (CNRS/UT3) Rémi Mascarau, PhD student in the « Phagocyte Architecture and[…]
6th Global Forum on TB Vaccines – Registration Open
Registration for the 6th Global Forum on TB Vaccines is now open !
Magali Jacquier is appointed member of the CNRS ethics committee
Magali Jacquier, veterinary doctor and scientific director of the ANEXPLO/IPBS platform, has been appointed for[…]
Creation of a CNRS Joint international laboratory headed by C. Vérollet and G. Lugo-Villarino
The International laboratory MAC-TB/HIV has just been recognized as a CNRS International Research Partnership (IRP)[…]